A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial

C. Fidler, Meredith; Sanchez, Matilde; Raether, Brian; J. Weissman, Neil; R. Smith, Steven; Shanahan, William; M. Anderson, Christen

doi:10.1210/jc.2011-1256

Public

A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial

Published in The Journal of Clinical Endocrinology & Metabolism • Jul 27, 2011

Authors:

Meredith C. Fidler

Matilde Sanchez

Brian Raether

Abstract

CONTEXT: Lorcaserin is a novel selective agonist of the serotonin 2C receptor. OBJECTIVE: Our objective was to evaluate the effects of lorcaserin on body weight, cardiovascular risk factors, and safety in obese and overweight patients. DESIGN AND SETTING: This randomized, placebo-controlled, double-...

Subject

Placebo

Medicine

Overweight

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!